Ananda Ghosh
Stock Analyst at HC Wainwright & Co.
(4.49)
# 171
Out of 5,090 analysts
15
Total ratings
64.29%
Success rate
24.42%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MAZE Maze Therapeutics | Maintains: Buy | $50 → $60 | $41.71 | +43.85% | 4 | Dec 3, 2025 | |
| PEPG PepGen | Maintains: Buy | $18 → $20 | $5.44 | +267.65% | 3 | Nov 13, 2025 | |
| DYN Dyne Therapeutics | Maintains: Buy | $38 → $46 | $20.28 | +126.82% | 1 | Nov 6, 2025 | |
| RNA Avidity Biosciences | Downgrades: Neutral | $87 → $72 | $71.63 | +0.52% | 2 | Oct 27, 2025 | |
| IVA Inventiva | Maintains: Buy | $20 → $24 | $4.13 | +481.11% | 2 | Oct 9, 2025 | |
| SKYE Skye Bioscience | Initiates: Buy | $20 | $1.20 | +1,566.67% | 1 | Sep 30, 2025 | |
| ANNX Annexon | Reiterates: Buy | $14 | $4.61 | +203.69% | 1 | Aug 15, 2025 | |
| GPCR Structure Therapeutics | Maintains: Buy | $75 → $60 | $34.56 | +73.61% | 1 | Aug 7, 2025 |
Maze Therapeutics
Dec 3, 2025
Maintains: Buy
Price Target: $50 → $60
Current: $41.71
Upside: +43.85%
PepGen
Nov 13, 2025
Maintains: Buy
Price Target: $18 → $20
Current: $5.44
Upside: +267.65%
Dyne Therapeutics
Nov 6, 2025
Maintains: Buy
Price Target: $38 → $46
Current: $20.28
Upside: +126.82%
Avidity Biosciences
Oct 27, 2025
Downgrades: Neutral
Price Target: $87 → $72
Current: $71.63
Upside: +0.52%
Inventiva
Oct 9, 2025
Maintains: Buy
Price Target: $20 → $24
Current: $4.13
Upside: +481.11%
Skye Bioscience
Sep 30, 2025
Initiates: Buy
Price Target: $20
Current: $1.20
Upside: +1,566.67%
Annexon
Aug 15, 2025
Reiterates: Buy
Price Target: $14
Current: $4.61
Upside: +203.69%
Structure Therapeutics
Aug 7, 2025
Maintains: Buy
Price Target: $75 → $60
Current: $34.56
Upside: +73.61%